Firm Secures $131.4 Million Judgment in HIV Drug Program Case
March, 2023 - United States of America
On March 7, 2023, the firm secured a $131.4 million default judgment on behalf of a leading biopharmaceutical company, against Florida-based clinics in connection with a fraudulent HIV medication scam.
The suit, initially filed in November 2020 in Florida federal court, alleges that two Florida-based healthcare networks engaged in schemes to defraud our client’s charitable medication assistance program for pre-exposure prophylaxis, or PrEP, a critical HIV infection prevention medication. According to the suit, the scam involved paying people experiencing homelessness to receive unwanted and unneeded medication. The clinics then claimed reimbursement for the medication through the company’s medication assistance program.
In the order granting the default judgment, the court awarded trebled actual damages to our client in the amount of $131.4 million.
